Feds: Morning-after pill appeal officially on hold

by Tom Hays
This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive. The federal government on Monday, June 10, 2013 told a judge it will reverse course and take steps to comply with his order to allow girls of any age to buy emergency contraception without prescriptions. (AP Photo/Barr Pharmaceuticals Inc., File)

A government appeal in the legal fight over allowing girls of any age to buy emergency contraception without prescriptions has officially been put on hold.

said Tuesday in a letter to a New York City appeals court both sides have agreed to stop litigating while they await a ruling from a lower-court judge.

The Department of Justice notified U.S. District Judge Edward Korman on Monday it had decided to reverse course and comply with his order to allow sales of the morning-after pills without age or other restrictions. It said it would withdraw the appeal of the order if the judge agrees with its plan to fast-track approval.

It's unclear when and how the judge will address the issue. A woman answering the phone in his chambers declined to comment.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US to allow morning-after pill for girls of any age

Jun 11, 2013

The Obama administration said Monday it would comply with a judge's order to allow women and girls of any age to purchase emergency contraception, ending its efforts to restrict the drug's availability.

Judge in NYC rips opposition to Plan B order

May 07, 2013

A federal judge, asked by the U.S. government on Tuesday to freeze his plan giving teenage girls broader access to morning-after birth control, instead seized the chance to accuse health officials of taking steps that would ...

Recommended for you

Determine patient preferences by means of conjoint analysis

17 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments